PDS Biotechnology Corp logo

PDS Biotechnology Corp

$ 3.19 +0.11 (+3.57%) 10:08 PM EST
P/E:
At Loss
P/B:
1.70
Market Cap:
$ 90.78M
Enterprise V:
$ 35.06M
Volume:
181.91K
Avg Vol (2M):
208.43K
Also Trade In:
Volume:
181.91K
Market Cap $:
90.78M
PE Ratio:
At Loss
Avg Vol (2-Month):
208.43K
Enterprise Value $:
35.06M
PB Ratio:
1.70
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
PDS Biotechnology Corp operates as a clinical-stage biotechnology company, principally involved in drug discovery in the United States. It is primarily engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
Name Current Vs Industry Vs History
Cash-To-Debt 134.14
Equity-to-Asset 0.92
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 37.93
9-Day RSI 31.84
14-Day RSI 33.5
6-1 Month Momentum % -27.44
12-1 Month Momentum % -71.98

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.34
Quick Ratio 12.34
Cash Ratio 11.73

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -162.5

Financials (Next Earnings Date:2022-11-10 Est.)

PDSB's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PDSB

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.99
Beta 2.15
Volatility % 46.5
14-Day RSI 33.5
14-Day ATR ($) 0.267762
20-Day SMA ($) 3.732
12-1 Month Momentum % -71.98
52-Week Range ($) 2.91 - 15.82
Shares Outstanding (Mil) 28.46

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PDS Biotechnology Corp Filings

Document Form Filing Date
No Filing Data

PDS Biotechnology Corp Analysis

Share your research

Headlines

See More
No news.